Neoplasms

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2016-11-02
Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients [Phase 1]
A Phase 1 study evaluating Onartuzumab in combination with Vemurafenib and/or Cobimetinib in cancer patients has been withdrawn. The documen…
CLINICAL_TRIALS withdrawal · 2015-04-22
Clinical Trial Update: Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome [Phase 2]
The Phase 2 trial of Everolimus for advanced malignancies in Peutz-Jeghers syndrome has been withdrawn.
CLINICAL_TRIALS withdrawal · 2015-04-01
Clinical Trial Update: SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I [Phase 3]
Phase 3 trial SHTC EUROPE-1 evaluating Synergo hyperthermia-chemotherapy for urinary bladder neoplasms has been withdrawn.
CLINICAL_TRIALS withdrawal · 2014-11-14
Clinical Trial Update: Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses [Phase 1]
Phase 1 trial of SS1(dsFv)-PE38 (SS1P) for advanced malignancies was withdrawn.
CLINICAL_TRIALS withdrawal · 2012-02-07
Clinical Trial Update: Japanese Phase 1 Study of BMS-844203 (CT322) [Phase 1]
A Japanese Phase 1 trial of Bristol-Myers Squibb's BMS-844203 (CT322) has been withdrawn.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.